currently used in women withmenopausal symptomswho have had a hysterectomy, may decreasebreast cancerrisk if it is used for fewer than five years. The study found this benefit persisted even after thehormone therapywas discontinued.
Nomura S, Suganuma T, Suzuki T, Ito T, Kajiyama H, Okada M, Shibata K, Ino K, Kikkawa F, Mizutani S.Endometrioid adenocarcinoma arising from endometriosis during 2 years of estrogen replacement therapy after total hysterectomy and bilateral salpingo-oophorectomy. Acta Obstetricia et Gynecologica ...
Unopposed Estrogen Therapy and the Risk of Invasive Breast Cancer Background: Although short-term unopposed estrogen use does not seem to increase breast cancer risk, the effect of longer-term estrogen use remains unclear... WY Chen,JAE Manson,SE Hankinson,... - 《Archives of Internal Medicine...
9,939 women aged 50 to 79 years with prior hysterectomy were included to examine whether estrogen therapy outcomes differed by whether or not the participants' ovaries were also removed. They also assessed whether the effect was different based on the age at which the women beganestrogen therapy...
After menopause, women experience a reduction in estrogen. This can lead to vaginal dryness, memory problems, hot flashes, fatigue, irritability and possibly one of the most devastating problems, a decrease in bone density. Although hormone replacement therapy has been controversial, with medical prof...
et al. Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS). Circulation.2001;103:638-642.Google Scholar 27. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ...
A few cases of malignant transformation of residual endometrial implants have been reported in women treated post-hysterectomy with estrogen alone therapy. For patients known to have residual endometriosis post-hysterectomy, the addition of progestin should be considered. 9. Exacerbation of other ...
26 Women without preexisting LSF based on the FSFI in KEEPS showed a gradual decline in sexual function after menopause independent of treatment regimen. While women with LSF at baseline benefited from menopausal hormone therapy, those without dysfunction did not appear to experience improved sexual ...
menopause before age 45 is sometimes referred to asearly menopause. Early or premature menopause may be induced if theovariesare surgically removed (for example, in ahysterectomyor intreatmentof ovarian cancer) or incidentally damaged or destroyed (as a side effect ofradiation therapyor chemotherapy)...
She is a Fellow of the American Society of Consultant Pharmacists and holds certifications in Medication Therapy Management and Advanced Diabetes Care. Dr. Wentz has dedicated her career to addressing the root causes of autoimmune thyroid disease, after being diagnosed with Hashimoto’s Thyroiditis in...